Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia-Reference-Cited by-同舟云学术

Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia

Published:2023-01-24 Issue:2 Volume:8 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Stölzel Friedrich^ORCID,Fordham Sarah E.^ORCID,Nandana Devi,Lin Wei-Yu^ORCID,Blair Helen,Elstob Claire,Bell Hayden L.^ORCID,Mohr Brigitte,Ruhnke Leo,Kunadt Desiree^ORCID,Dill Claudia,Allsop Daniel,Piddock Rachel,Soura Emmanouela-Niki,Park Catherine,Fadly Mohd^ORCID,Rahman Thahira,Alharbi Abrar,Wobus Manja^ORCID,Altmann Heidi,Röllig Christoph^ORCID,Wagenführ Lisa,Jones Gail L.,Menne Tobias,Jackson Graham H.,Marr Helen J.,Fitzgibbon Jude,Onel Kenan,Meggendorfer Manja,Robinson Amber,Bziuk Zuzanna,Bowes Emily,Heidenreich Olaf^ORCID,Haferlach Torsten,Villar Sara,Ariceta Beñat^ORCID,Diaz Rosa Ayala,Altschuler Steven J.^ORCID,Wu Lani F.,Prosper Felipe,Montesinos Pau,Martinez-Lopez Joaquin^ORCID,Bornhäuser Martin^ORCID,Allan James M.^ORCID

Funder

Blood Cancer UK

German Consortium for Translational Cancer Research

JGW Patterson Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/150368/files/pdf

Reference64 articles.

1. Genomic Classification and Prognosis in Acute Myeloid Leukemia

2. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with aFLT3Mutation

3. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]

4. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group [see comments]

5. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia;Leukemia & Lymphoma;2024-07-14

2. Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol;Cancers;2023-06-05